A client with a mechanical mitral valve had warfarin-associated retroperitoneal bleeding with shock and INR 6.8. Warfarin was held, authorized 4-factor PCC and vitamin K were administered, and source control was completed. Review the post-reversal trend and select the best interpretation and ongoing medication plan.
Trend
Choose your responses, then check the answer.
Explanation
Hemodynamics, hemoglobin, INR, renal function, and imaging are improving, indicating hemostatic response. The mechanical mitral valve remains a high-risk thrombotic indication, so anticoagulation resumption requires a documented specialist plan rather than permanent unplanned discontinuation.
Quick answer The bleed is improving, but the valve indication remains.
Why this is correct Normalized perfusion and stabilized hemoglobin support bleeding control. A mechanical mitral valve still requires VKA-based long-term protection, so restart timing and bridging decisions must be individualized after hemostasis.
Easy analogy or mental picture The emergency brake worked, but the long-term anti-clot engine still has to be restarted safely.
Memory hook Hemostasis achieved does not mean anticoagulation indication erased.
NCLEX decision rule Evaluate bleeding control and thrombotic need together before documenting the next phase.
Why the other choices are wrong Immediate full-dose restart ignores rebleeding risk, while permanent discontinuation without a plan ignores valve thrombosis risk.
References
1DailyMed: Warfarin SodiumMajor bleeding, INR monitoring, pregnancy and mechanical-valve risk, and therapy individualization
2ACC/AHA 2020 Valvular Heart Disease GuidelineVKA therapy for mechanical valves, pregnancy counseling, and monitored anticoagulation planning
Post-reversal monitoringEvaluate hemodynamics, hemoglobin, INR, renal function, bleeding control, and the unresolved thrombotic indication before deciding the next anticoagulation step.